B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
Nature Biotechnology, published online: March 10, 2026; doi:10.1038/s41587-026-03069-5
Profound depletion of B cells yields transformative clinical outcomes in autoimmune diseases. Negotiators bet on the best tools for the job.
